Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57,523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers - A real-life prospective study.
Zheng M, Sima Y, Liu C, Zhao J, Shao S, Wang X, Wang Y, Cao F, Xiong W, Wang X, Zhang L. Zheng M, et al. Among authors: zhao j. World Allergy Organ J. 2022 Sep 23;15(10):100702. doi: 10.1016/j.waojou.2022.100702. eCollection 2022 Oct. World Allergy Organ J. 2022. PMID: 36254182 Free PMC article.
15-Lipoxygenase 1 in nasal polyps promotes CCL26/eotaxin 3 expression through extracellular signal-regulated kinase activation.
Li Z, Zeng M, Deng Y, Zhao J, Zhou X, Trudeau JB, Goldschmidt E, Moore JA, Chu H, Zhang W, Yin S, Liu Z, Di YP, Lee SE, Wenzel SE. Li Z, et al. Among authors: zhao j. J Allergy Clin Immunol. 2019 Nov;144(5):1228-1241.e9. doi: 10.1016/j.jaci.2019.06.037. Epub 2019 Jul 11. J Allergy Clin Immunol. 2019. PMID: 31301373 Free PMC article.
57,523 results
You have reached the last available page of results. Please see the User Guide for more information.